Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia

被引:0
|
作者
Zhi-ling Zhou
Xin Li
Huai-yan Peng
Xi-yong Yu
Ming Yang
Feng-li Su
Feng Wang
Rong-hua Zhu
Chun-yu Deng
Qiu-xiong Lin
Chuan-yue Wang
Wen-biao Li
Shu-guang Lin
Huan-de Li
机构
[1] Clinical Pharmacy Research Institute,Vascular Surgery Department
[2] Xiangya Second Hospital,Department of Clinical Laboratory
[3] Central South University,undefined
[4] Research Center of Medical Science,undefined
[5] Guangdong Provincial People's Hospital,undefined
[6] Xiangya Second Hospital,undefined
[7] Central South University,undefined
[8] Third Xiangya Hospital,undefined
[9] Central South University,undefined
[10] Affiliated Beijing An Ding Hospital,undefined
[11] Capital University of Medical Science,undefined
来源
Acta Pharmacologica Sinica | 2006年 / 27卷
关键词
pharmacokinetics; risperidone; 9-hydroxyrisperidone; schizophrenia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:381 / 386
页数:5
相关论文
共 50 条
  • [31] Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders
    Jones, Tanya
    Van Breda, Karin
    Charles, Bruce
    Dean, Angela J.
    McDermott, Brett M.
    Norris, Ross
    BIOMEDICAL CHROMATOGRAPHY, 2009, 23 (09) : 929 - 934
  • [32] Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder
    Duval, Fabrice
    Guillon, Marie-Sabine
    Mokrani, Marie-Claude
    Crocq, Marc-Antoine
    Duarte, Frederico Garcia
    PSYCHONEUROENDOCRINOLOGY, 2008, 33 (02) : 255 - 259
  • [33] Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry
    Aravagiri, M
    Marder, SR
    JOURNAL OF MASS SPECTROMETRY, 2000, 35 (06): : 718 - 724
  • [34] LC with Column-Switching and Spectrophotometric Detection for Determination of Risperidone and 9-Hydroxyrisperidone in Human Serum
    Katrin M. Kirschbaum
    Susann Finger
    Friederike Vogel
    Rainer Burger
    Manfred Gerlach
    Peter Riederer
    Christoph Hiemke
    Chromatographia, 2008, 67 : 321 - 324
  • [35] Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
    Mandrioli, Roberto
    Mercolini, Laura
    Lateana, Domenico
    Boncompagni, Giancarlo
    Raggi, Maria Augusta
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (02): : 167 - 173
  • [36] Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection
    Locatelli, Igor
    Mrhar, Ales
    Grabnar, Iztok
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (05) : 905 - 910
  • [37] Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone
    Aravagiri, M
    Marder, SR
    Nuechterlein, KH
    Gitlin, MJ
    THERAPEUTIC DRUG MONITORING, 2003, 25 (06) : 657 - 664
  • [38] Effect of Cyamemazine on the Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone: A Preliminary Retrospective Study
    Lancelin, Frederique
    Bourcier, Elsa
    Le Masson, Valerie
    Lemeille, Yolande
    Brovedani, Sophie
    Paubel, Pascal
    Piketty, Marie-Liesse
    THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 757 - 761
  • [39] Serum Levels of Risperidone and Its Metabolite, 9-Hydroxyrisperidone: Correlation Between Drug Concentration and Clinical Response
    Lostia, Alfonso M.
    Mazzarini, Lorenzo
    Pacchiarotti, Isabella
    Lionetto, Luana
    De Rossi, Pietro
    Sanna, Livia
    Sani, Gabriele
    Kotzalidis, Giorgio D.
    Girardi, Paolo
    Simmaco, Maurizio
    Tatarelli, Roberto
    THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 475 - 481
  • [40] Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients
    Jung, SM
    Kim, KA
    Cho, HK
    Jung, IG
    Park, PW
    Byun, WT
    Park, JY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (05) : 520 - 528